There is no excerpt because this is a protected post.
Read moreWe're delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We'll...
Read moreOur latest article discusses key strategies for pharma manufacturers' commercial readiness for EU HT...
Read moreWe summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova...
Read moreWe discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea...
Read moreLearn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...
Read moreBack in January this year, we summarised the key trends our market access experts believed would dom...
Read moreWe summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...
Read moreOur research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...
Read moreOur market access experts provide an overview of how to get payer scientific advice between Septembe...
Read more